|Date & Time||2 February 2023 (9:00-16:00 CET)|
The European Medicines Agency (EMA) is organising a virtual conference on 2 February 2023.
The aim of the conference is to promote the development of RNA-based medicines by:
- Identifying scientific and regulatory opportunities and challenges of RNA-based innovative medicines;
- Facilitating dialogue between industry/academia and regulators and raising awareness on scientific and regulatory aspects;
- Identifying gaps in regulatory science.
This initiative addresses Goal 1 (catalysing the integration of science and technology in medicines development) of the EMA Regulatory Science Strategy to 2025.
The conference focuses on emerging RNA technologies beyond vaccines. Please see the programme for more details.
The event is open to all stakeholders, registration enables active participation. The event will be broadcast and recorded, and the videos will be made available after the event. Please register here by 27 January 2023.